Symptomatic isolated internal carotid artery occlusion with initial medical management: a monocentric cohort.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 02 05 2020
accepted: 24 07 2020
revised: 20 07 2020
pubmed: 19 8 2020
medline: 22 6 2021
entrez: 19 8 2020
Statut: ppublish

Résumé

Symptomatic isolated carotid artery occlusions (ICAO) can lead to disability, recurrent stroke, and mortality, but natural history and best therapeutic management remain poorly known. The objective of this study was to describe our cohort of ICAO patients with an initial medical management. We conducted a retrospective study including consecutive patients admitted to our Comprehensive Stroke Center for ICAO within 24 h after stroke onset between January 2016 and September 2018. Patients with immediate endovascular therapy (EVT) were excluded. Medical treatment was based on anticoagulation (delayed by 24 h if intravenous thrombolysis was performed). 'Rescue' EVT was considered if first-week neurological deterioration (FWND) occurred. Fifty-six patients were included, with a median National Institutes of Health Stroke Scale (NIHSS) of 3. Eleven patients (20%) had FWND during the first week, four benefited from rescue EVT. A mismatch volume > 40 cc on initial perfusion imaging and FLAIR vascular hyperintensities were associated with FWND (p = 0.007 and p = 0.009, respectively). Thirty-eight patients (69%) had a good outcome (modified Rankin Scale mRS 0-2) at 3 months, 36 (69%) had an excellent outcome (mRS 0-1). Seventeen patients (38%) had carotid patency on 3-month control imaging. Recurrences occurred in six (13%) of the survivors (mean follow-up: 13.6 months). Our results suggest that the prognosis of patients with acute ICAO was favorable with a medical strategy, albeit a substantial rate of FWND and recurrence. FWND was well predicted by a core-perfusion mismatch volume > 40 cc. Randomized controlled trials are necessary to assess the benefit of EVT in ICAO.

Sections du résumé

BACKGROUND BACKGROUND
Symptomatic isolated carotid artery occlusions (ICAO) can lead to disability, recurrent stroke, and mortality, but natural history and best therapeutic management remain poorly known. The objective of this study was to describe our cohort of ICAO patients with an initial medical management.
METHODS METHODS
We conducted a retrospective study including consecutive patients admitted to our Comprehensive Stroke Center for ICAO within 24 h after stroke onset between January 2016 and September 2018. Patients with immediate endovascular therapy (EVT) were excluded. Medical treatment was based on anticoagulation (delayed by 24 h if intravenous thrombolysis was performed). 'Rescue' EVT was considered if first-week neurological deterioration (FWND) occurred.
RESULTS RESULTS
Fifty-six patients were included, with a median National Institutes of Health Stroke Scale (NIHSS) of 3. Eleven patients (20%) had FWND during the first week, four benefited from rescue EVT. A mismatch volume > 40 cc on initial perfusion imaging and FLAIR vascular hyperintensities were associated with FWND (p = 0.007 and p = 0.009, respectively). Thirty-eight patients (69%) had a good outcome (modified Rankin Scale mRS 0-2) at 3 months, 36 (69%) had an excellent outcome (mRS 0-1). Seventeen patients (38%) had carotid patency on 3-month control imaging. Recurrences occurred in six (13%) of the survivors (mean follow-up: 13.6 months).
CONCLUSION CONCLUSIONS
Our results suggest that the prognosis of patients with acute ICAO was favorable with a medical strategy, albeit a substantial rate of FWND and recurrence. FWND was well predicted by a core-perfusion mismatch volume > 40 cc. Randomized controlled trials are necessary to assess the benefit of EVT in ICAO.

Identifiants

pubmed: 32809152
doi: 10.1007/s00415-020-10118-9
pii: 10.1007/s00415-020-10118-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

346-355

Références

Powers WJ (2003) Atherosclerotic carotid artery occlusion. Curr Treat Options Cardiovasc Med 5:501–509. https://doi.org/10.1007/s11936-003-0039-3
doi: 10.1007/s11936-003-0039-3 pubmed: 14575627
Flaherty ML, Flemming KD, McClelland R et al (2004) Population-based study of symptomatic internal carotid artery occlusion: incidence and long-term follow-up. Stroke 35:e349–e352. https://doi.org/10.1161/01.STR.0000135024.54608.3f
doi: 10.1161/01.STR.0000135024.54608.3f pubmed: 15232124
Paciaroni M, Caso V, Venti M et al (2005) Outcome in patients with stroke associated with internal carotid artery occlusion. Cerebrovasc Dis 20:108–113. https://doi.org/10.1159/000086800
doi: 10.1159/000086800 pubmed: 16006758
Paciaroni M, Agnelli G, Caso V et al (2012) Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. Cerebrovasc Dis 34:430–435. https://doi.org/10.1159/000345081
doi: 10.1159/000345081 pubmed: 23207482
Hankey GJ, Warlow CP (1991) Prognosis of symptomatic carotid artery occlusion. Cerebrovasc Dis 1:245–256. https://doi.org/10.1159/000108851
doi: 10.1159/000108851
Klijn CJ, Kappelle LJ, Tulleken CA, van Gijn J (1997) Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke 28:2084–2093. https://doi.org/10.1161/01.str.28.10.2084
doi: 10.1161/01.str.28.10.2084 pubmed: 9341723
Klijn CJM, van Buren PA, Kappelle LJ et al (2000) Outcome in patients with symptomatic occlusion of the internal carotid artery. Eur J Vasc Endovasc Surg 19:579–586. https://doi.org/10.1053/ejvs.2000.1129
doi: 10.1053/ejvs.2000.1129 pubmed: 10873724
Grubb RL, Derdeyn CP, Fritsch SM et al (1998) Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 280:6. https://doi.org/10.1001/jama.280.12.1055
doi: 10.1001/jama.280.12.1055
Lanari A, Silvestrelli G (2012) Acute and chronic carotid occlusion syndromes. In: Paciaroni M, Agnelli G, Caso V, Bogousslavsky J (eds) Frontiers of neurology and neuroscience. Karger, Basel, pp 185–190
Bhatia R, Hill MD, Shobha N et al (2010) Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 41:2254–2258. https://doi.org/10.1161/STROKEAHA.110.592535
doi: 10.1161/STROKEAHA.110.592535 pubmed: 20829513 pmcid: 20829513
Paciaroni M, Balucani C, Agnelli G et al (2012) Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: the ICARO study. Stroke 43:125–130. https://doi.org/10.1161/STROKEAHA.111.630624
doi: 10.1161/STROKEAHA.111.630624 pubmed: 22034003
Yeo LLL, Kong WY, Paliwal P et al (2016) Intravenous thrombolysis for acute ischemic stroke due to cervical internal carotid artery occlusion. J Stroke Cerebrovasc Dis 25:2423–2429. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.06.014
doi: 10.1016/j.jstrokecerebrovasdis.2016.06.014 pubmed: 27344361
Goyal M, Menon BK, van Zwam WH et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet Lond Engl 387:1723–1731. https://doi.org/10.1016/S0140-6736(16)00163-X
doi: 10.1016/S0140-6736(16)00163-X
Mokin M, Kass-Hout T, Kass-Hout O et al (2012) Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: a systematic review of clinical outcomes. Stroke 43:2362–2368. https://doi.org/10.1161/STROKEAHA.112.655621
doi: 10.1161/STROKEAHA.112.655621 pubmed: 22811456
Paciaroni M, Inzitari D, Agnelli G et al (2015) Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study. J Neurol 262:459–468. https://doi.org/10.1007/s00415-014-7550-1
doi: 10.1007/s00415-014-7550-1 pubmed: 25451851
Jadhav A, Panczykowski D, Jumaa M et al (2018) Angioplasty and stenting for symptomatic extracranial non-tandem internal carotid artery occlusion. J NeuroInterv Surg 10:1155–1160. https://doi.org/10.1136/neurintsurg-2018-013810
doi: 10.1136/neurintsurg-2018-013810 pubmed: 29706606
Adams HP, Bendixen BH, Leira E et al (1999) Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53:122–125. https://doi.org/10.1212/wnl.53.1.122
doi: 10.1212/wnl.53.1.122 pubmed: 10408547
Damania D, Kung NT-M, Jain M et al (2016) Factors associated with recurrent stroke and recanalization in patients presenting with isolated symptomatic carotid occlusion. Eur J Neurol 23:127–132. https://doi.org/10.1111/ene.12819
doi: 10.1111/ene.12819 pubmed: 26332023
EC/IC Bypass Study Group (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. N Engl J Med 313:1191–1200. https://doi.org/10.1056/NEJM198511073131904
doi: 10.1056/NEJM198511073131904
Powers WJ, Clarke WR, Grubb RL et al (2011) Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the carotid occlusion surgery study randomized trial. JAMA 306:1983–1992. https://doi.org/10.1001/jama.2011.1610
doi: 10.1001/jama.2011.1610 pubmed: 22068990 pmcid: 3601825
Seners P, Turc G, Tisserand M et al (2014) Unexplained early neurological deterioration after intravenous thrombolysis: incidence, predictors, and associated factors. Stroke 45:2004–2009. https://doi.org/10.1161/STROKEAHA.114.005426
doi: 10.1161/STROKEAHA.114.005426 pubmed: 24876087
Kernan WN, Ovbiagele B, Black HR et al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45:2160–2236. https://doi.org/10.1161/STR.0000000000000024
doi: 10.1161/STR.0000000000000024 pubmed: 24788967
Rebello LC, Bouslama M, Haussen DC et al (2017) Endovascular treatment for patients with acute stroke who have a large ischemic core and large mismatch imaging profile. JAMA Neurol 74:34. https://doi.org/10.1001/jamaneurol.2016.3954
doi: 10.1001/jamaneurol.2016.3954 pubmed: 27820620
Hacke W (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA J Am Med Assoc 274:1017–1025. https://doi.org/10.1001/jama.274.13.1017
doi: 10.1001/jama.274.13.1017
Adams HP, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41. https://doi.org/10.1161/01.STR.24.1.35
doi: 10.1161/01.STR.24.1.35 pubmed: 7678184
Hause S, Oldag A, Breja A et al (2019) Acute symptomatic extracranial internal carotid occlusion—natural course and clinical impact. Vasa. https://doi.org/10.1024/0301-1526/a000826
doi: 10.1024/0301-1526/a000826 pubmed: 31621550
Albers GW, Marks MP, Kemp S et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708–718. https://doi.org/10.1056/NEJMoa1713973
doi: 10.1056/NEJMoa1713973 pubmed: 29364767 pmcid: 6590673
Mazya MV, Cooray C, Lees KR et al (2018) Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register. Eur Stroke J 3:29–38. https://doi.org/10.1177/2396987317746003
doi: 10.1177/2396987317746003 pubmed: 31008335
Xu B, Li C, Guo Y et al (2017) Current understanding of chronic total occlusion of the internal carotid artery (review). Biomed Rep. https://doi.org/10.3892/br.2017.1033
doi: 10.3892/br.2017.1033 pubmed: 29435280 pmcid: 5776422
Legrand L, Tisserand M, Turc G et al (2015) Do FLAIR vascular hyperintensities beyond the DWI lesion represent the ischemic penumbra? Am J Neuroradiol 36:269–274. https://doi.org/10.3174/ajnr.A4088
doi: 10.3174/ajnr.A4088 pubmed: 25190202
Saver JL, Goyal M, Bonafe A et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372:2285–2295. https://doi.org/10.1056/NEJMoa1415061
doi: 10.1056/NEJMoa1415061 pubmed: 25882376
Campbell BCV, Mitchell PJ, Kleinig TJ et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372:1009–1018. https://doi.org/10.1056/NEJMoa1414792
doi: 10.1056/NEJMoa1414792 pubmed: 25671797
Dargazanli C, Arquizan C, Gory B et al (2017) Mechanical thrombectomy for minor and mild stroke patients harboring large vessel occlusion in the anterior circulation: a multicenter cohort study. Stroke 48:3274–3281. https://doi.org/10.1161/STROKEAHA.117.018113
doi: 10.1161/STROKEAHA.117.018113 pubmed: 29089458
Cagnazzo F, Dargazanli C, Lefevre P-H et al (2019) Chronic occlusion of the internal carotid artery: endovascular revascularization technique of long occlusive lesions. J Neuroradiol. https://doi.org/10.1016/j.neurad.2019.05.005
doi: 10.1016/j.neurad.2019.05.005 pubmed: 31229577

Auteurs

Adrien Ter Schiphorst (A)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Nicolas Gaillard (N)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Cyril Dargazanli (C)

Department of Neuroradiology, CHRU Gui de Chauliac, Montpellier, France.

Isabelle Mourand (I)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Lucas Corti (L)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Mahmoud Charif (M)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Xavier Ayrignac (X)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Anaïs Lippi (A)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Stéphane Bouly (S)

Department of Neurology, CHRU Carémeau, Nîmes, France.

Lalu Thibault (L)

Department of Neurology, CH de Béziers, Béziers, France.

Denis Sablot (D)

Department of Neurology, CH de Perpignan, Perpignan, France.

Genevieve Blanchet-Fourcade (G)

Department of Neurology, CH de Narbonne, Narbonne, France.

Nicolas Landragin (N)

Department of Neurology, Clinique du Millénaire, Montpellier, France.

Vincent Costalat (V)

Department of Neuroradiology, CHRU Gui de Chauliac, Montpellier, France.

Claire Duflos (C)

Clinical Research and Epidemiology Unit, CHU, University Montpellier, Montpellier, France.

Caroline Arquizan (C)

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France. c-arquizan@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH